Other substances

Trabectedin

A natural tetrahydroisoquinoline alkaloid with antineoplastic properties.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Trabectedin on PubChem

Marketed as

YONDELIS

 

Structure image - Trabectedin

CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O

Supporting references

Link Tested on Impact factor Notes Publication date
Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors
3CLpro Small molecule In silico 		in silico 3.27

Predicted to inhibit SARS-CoV-2 3C-like protease.

 Feb/10/2021
Export (.csv)